Clinical Research Directory
Browse clinical research sites, groups, and studies.
Atropine 0.01% Eyedrops for Evolutive Myopia Treatment in Children
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Summary
Prevalence of myopia and its complications has been increasing over the past decades, especially among children and adolescents. It reaches record levels in Asia: nearly 80% of the population in some regions in 2012 where the investigators speak in terms of epidemic. ATROPINE 0.01% eyedrops one drop per day is today an evolutive myopia treatment, whose results are promising. The investigators use this eye drops in our clinical practice at hospital of Saint-Etienne since 2017. Few clinical data have been published so far concerning the French population. The investigators would like to build a database so that the investigators can publish our results and share our experience.
Official title: Atropine 0.01% Eyedrops for Evolutive Myopia Treatment in Children. MYOPSTOP
Key Details
Gender
All
Age Range
Any - 18 Years
Study Type
OBSERVATIONAL
Enrollment
50
Start Date
2019-12-18
Completion Date
2027-12
Last Updated
2025-03-18
Healthy Volunteers
No
Interventions
data collection
* Demographic data: age, sex * Ophthalmological history: refraction of parents, previous refractions * Ophthalmological data at each examination: intra-ocular pression, objective refraction after "fog", cycloplegia with SKIACOL, slit lamp, dilated eye exam, biometrics * Potential undesirable events (halos, photophobia...)
Locations (1)
CHU de Saint Etienne
Saint-Etienne, France